• Share
  • Email
  • Embed
  • Like
  • Save
  • Private Content
CBSA Names Logan Collins, Fairview High School Junior, As Colorado’s BioGENEius Finalist
 

CBSA Names Logan Collins, Fairview High School Junior, As Colorado’s BioGENEius Finalist

on

  • 98 views

Logan Collins, a junior at Boulder’s Fairview High School, was named winner of Colorado’s 2014 BioGENEius Challenge at a statewide competition held during April at the Colorado Science and ...

Logan Collins, a junior at Boulder’s Fairview High School, was named winner of Colorado’s 2014 BioGENEius Challenge at a statewide competition held during April at the Colorado Science and Engineering Fair in Fort Collins. The announcement is made by Colorado BioScience Association (CBSA) President and CEO April Giles, who says, “This is the first year for the competition in Colorado. We’re proud that Logan will represent our state and move on to compete against students from the U.S. and Canada at the International BioGENEius Challenge, held June 20-24 at the 2014 BIO International Convention in San Diego.”

Statistics

Views

Total Views
98
Views on SlideShare
98
Embed Views
0

Actions

Likes
0
Downloads
0
Comments
0

0 Embeds 0

No embeds

Accessibility

Categories

Upload Details

Uploaded via as Adobe PDF

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

    CBSA Names Logan Collins, Fairview High School Junior, As Colorado’s BioGENEius Finalist CBSA Names Logan Collins, Fairview High School Junior, As Colorado’s BioGENEius Finalist Document Transcript

    •   Colorado BioScience Association Names Logan Collins, Fairview High School Junior, As Colorado’s BioGENEius Finalist   Logan Collins Advances to San Diego to Compete Against Top Students   From Across the Nation and Canada    Denver, CO – May 1, 2014 ‐‐ Logan Collins, a junior at Boulder’s Fairview High School, was named  winner of Colorado’s 2014 BioGENEius Challenge at a statewide competition held during April at the  Colorado Science and Engineering Fair in Fort Collins.     The announcement is made by Colorado BioScience Association (CBSA) President & CEO April Giles, who  says, “This is the first year for the competition in Colorado. We’re proud that Logan will represent our  state and move on to compete against students from the U.S. and Canada at the International  BioGENEius Challenge, held June 20‐24 at the 2014 BIO International Convention in San Diego.”    The title of Collins’ presentation is: “The Conjugative Plasmid RK2 As a Delivery System for Artificial AnatheriaH Genes: A Novel Synthetic Biology Alternative to Traditional Antibiotics.” As the Colorado winner,  Collins receives a travel stipend for the San Diego competition, along with one chaperone.    The first place winner in the International competition will receive a $7,500 cash prize, the second place  winner will receive $5,000, the third place winner will receive $2,500 and the fourth place winner will  receive $1,000.      The Challenge provides students with the biotechnology skills and knowledge needed to succeed in the  Biotech Industry in the future. The competition is sponsored by Sanofi Pasteur, the vaccines division of  leading global pharmaceutical company Sanofi, and Janssen Pharmaceutical Companies of Johnson &  Johnson.    “Students are rapidly gaining interest in the sciences, and the BioGENEius Challenge has found a way to  encourage those students who are excited about biotechnology to take the next step in their research,”  said Mark Lievonen, President of Sanofi Pasteur Limited.  “We are thrilled to participate in a program  that cultivates young, innovative minds to address our global challenges in new ways.”    “Biotechnology offers an avenue to address some of the most pressing issues of our time. Through the  BioGENEius Challenge students gain an appreciation for the fascinating aspects and tremendous  potential of scientific experimentation,” added Jay P. Siegel, M.D., Chief Biotechnology Officer and Head  of Scientific Strategy and Policy for Johnson & Johnson.  “It is our expectation that this program will  draw bright young people into the endeavor of biotechnology and help accelerate the development of  the next‐generation of scientists.”    ‐More‐ 
    • Page 2      In addition to Sanofi Pasteur and Janssen, support for the BioGENEius Challenge is provided by  International Supporter: Genentech; and U.S. National Supporters: Acorda Therapeutics, The Allergan  Foundation, Pfizer and Sangamo BioSciences.    Throughout the challenge, @BiotechInstitut will be tweeting interviews, photos, and engaging with the  biotechnology community by using the hashtag #BioGENEius.    About the Biotechnology Institute  The Biotechnology Institute is an independent, national nonprofit organization dedicated to education  about the present and future impact of biotechnology.  Its mission is to engage, excite and educate the  public, particularly students and teachers, about biotechnology and its immense potential for solving  human health, food and environmental problems. Visit http://www.biotechinstitute.org.     About Sanofi  Sanofi, an integrated global healthcare leader, discovers, develops and distributes therapeutic solutions  focused on patients’ needs. Sanofi has core strengths in the field of healthcare with seven growth  platforms: diabetes solutions, human vaccines, innovative drugs, consumer healthcare, emerging  markets, animal health and the new Genzyme. Sanofi is listed in Paris (EURONEXT: SAN) and in New York  (NYSE: SNY). Sanofi Pasteur, the vaccines division of Sanofi, provides more than 1 billion doses of vaccine  each year, making it possible to immunize more than 500 million people across the globe. A world  leader in the vaccine industry, Sanofi Pasteur offers a broad range of vaccines protecting against 20  infectious diseases. The company's heritage, to create vaccines that protect life, dates back more than a  century. Sanofi Pasteur is the largest company entirely dedicated to vaccines. Every day, the company  invests more than EUR 1 million in research and development. Visit: http://www.sanofipasteur.com or  http://www.sanofipasteur.us.     About Janssen   At Janssen we are dedicated to addressing and solving some of the most important unmet medical  needs of our time in oncology, immunology, neuroscience, infectious diseases and vaccines, and  cardiovascular and metabolic diseases. Driven by our commitment to patients, we develop innovative  products, services and healthcare solutions to help people throughout the world.  Visit:  http://www.janssenrnd.com.     About Colorado BioScience Association  CBSA is a not‐for‐profit organization providing services and support for Colorado's bioscience industry.  With more than 350 members, CBSA actively works to promote the growth of the industry by  advocating for a better business environment, growing the state's biotech workforce, fighting for  policies that support a strong bioscience industry in the state, and speaking with a single voice on behalf  of the industry. Visit http://www.cobioscience.com.   CBSA also is found on these social media sites:   Twitter: http://www.twitter.com/COBioscience     LinkedIn Group: http://www.linkedin.com/groups?about=&gid=98468&trk=anet_ug_grppro       ‐More‐ 
    • Page 3    Facebook Fan Page: http://www.facebook.com/ColoradoBioScienceAssociation   News Feed:  http://coloradobio.blogspot.com    YouTube Channel: http://www.youtube.com/COBioscience    Pinterest: http://pinterest.com/COBioscience     Tumblr: http://cobioscience.tumblr.com    Contacts:  Mae Desaire, Director of Marketing, Colorado BioScience Association ‐ http://www.cobioscience.com  –   720‐382‐5918, mdesaire@cobioscience.com       Maggie Chamberlin Holben, APR, Absolutely Public Relations ‐ http://www.absolutelypr.com  ‐   303‐984‐9801, maggie@absolutelypr.com